Integrated Advisors Network LLC Sells 171 Shares of Aflac Incorporated (NYSE:AFL)

Integrated Advisors Network LLC lowered its stake in shares of Aflac Incorporated (NYSE:AFL) by 2.6% during the 3rd quarter, according to its most recent filing with the SEC. The firm owned 6,472 shares of the financial services provider’s stock after selling 171 shares during the period. Integrated Advisors Network LLC’s holdings in Aflac were worth $724,000 as of its most recent SEC filing.

Other institutional investors have also recently made changes to their positions in the company. Norden Group LLC bought a new stake in Aflac in the 1st quarter worth approximately $3,249,000. Van ECK Associates Corp increased its position in Aflac by 6.9% during the first quarter. Van ECK Associates Corp now owns 90,505 shares of the financial services provider’s stock valued at $7,771,000 after acquiring an additional 5,837 shares during the last quarter. J.W. Cole Advisors Inc. lifted its holdings in Aflac by 5.2% in the first quarter. J.W. Cole Advisors Inc. now owns 15,520 shares of the financial services provider’s stock valued at $1,325,000 after acquiring an additional 766 shares during the period. Diversify Advisory Services LLC purchased a new position in Aflac in the first quarter worth about $1,145,000. Finally, Mirae Asset Global Investments Co. Ltd. increased its position in shares of Aflac by 17.0% during the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 167,204 shares of the financial services provider’s stock valued at $14,356,000 after purchasing an additional 24,284 shares during the last quarter. Hedge funds and other institutional investors own 67.44% of the company’s stock.

Aflac Stock Performance

AFL opened at $104.79 on Friday. The company has a debt-to-equity ratio of 0.29, a quick ratio of 0.10 and a current ratio of 0.10. The stock has a market capitalization of $59.54 billion, a price-to-earnings ratio of 11.57, a PEG ratio of 2.62 and a beta of 0.95. The company has a fifty day moving average of $110.58 and a 200 day moving average of $97.51. Aflac Incorporated has a fifty-two week low of $75.07 and a fifty-two week high of $115.50.

Aflac (NYSE:AFL) last issued its quarterly earnings data on Wednesday, October 30th. The financial services provider reported $2.16 earnings per share for the quarter, beating analysts’ consensus estimates of $1.70 by $0.46. The firm had revenue of $2.95 billion during the quarter, compared to analyst estimates of $4.30 billion. Aflac had a return on equity of 16.22% and a net margin of 28.35%. The business’s quarterly revenue was down 40.4% compared to the same quarter last year. During the same quarter last year, the business posted $1.84 earnings per share. As a group, sell-side analysts forecast that Aflac Incorporated will post 6.76 earnings per share for the current fiscal year.

Aflac Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, December 2nd. Stockholders of record on Wednesday, November 20th will be issued a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 1.91%. Aflac’s dividend payout ratio (DPR) is 22.08%.

Insider Activity

In related news, Director Thomas J. Kenny sold 2,000 shares of the business’s stock in a transaction on Wednesday, August 7th. The shares were sold at an average price of $98.94, for a total value of $197,880.00. Following the sale, the director now owns 18,158 shares in the company, valued at approximately $1,796,552.52. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Corporate insiders own 0.90% of the company’s stock.

Analysts Set New Price Targets

Several analysts recently issued reports on AFL shares. Morgan Stanley boosted their target price on shares of Aflac from $91.00 to $98.00 and gave the company an “equal weight” rating in a research report on Monday, August 19th. Bank of America upped their price objective on Aflac from $115.00 to $124.00 and gave the stock a “buy” rating in a research note on Thursday, October 10th. Wells Fargo & Company lifted their target price on Aflac from $90.00 to $106.00 and gave the company an “equal weight” rating in a research report on Thursday, October 10th. Barclays assumed coverage on Aflac in a research report on Wednesday, September 4th. They issued an “underweight” rating and a $96.00 price target for the company. Finally, Citigroup boosted their price objective on Aflac from $84.00 to $93.00 and gave the company a “neutral” rating in a research note on Tuesday, July 23rd. Three analysts have rated the stock with a sell rating, ten have issued a hold rating and three have assigned a buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $97.53.

Aflac Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.